Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Kathleen M Neuzil, Vadim Tsvetnitsky, Linda J Nyari, Rick A Bright & John W Boslego. (2012) PATH Influenza Vaccine Project: accelerating the development of new influenza vaccines for low-resource countries. Expert Review of Vaccines 11:8, pages 939-947.
Read now
Read now
Varough M Deyde & Larisa V Gubareva. (2009) Influenza genome analysis using pyrosequencing method: current applications for a moving target. Expert Review of Molecular Diagnostics 9:5, pages 493-509.
Read now
Read now
Articles from other publishers (17)
Majed Ghattas, Garima Dwivedi, Marc Lavertu & Mohamad-Gabriel Alameh. (2021) Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities. Vaccines 9:12, pages 1490.
Crossref
Crossref
Zheng Jin, Shuang Gao, Xianlan Cui, Dejun Sun & Kai Zhao. (2019) Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines. International Journal of Pharmaceutics 572, pages 118731.
Crossref
Crossref
Prashant Kumar & Mansi Srivastava. (2018) Prophylactic and therapeutic approaches for human metapneumovirus. VirusDisease 29:4, pages 434-444.
Crossref
Crossref
Yoon Jae Lee, Yo Han Jang, Paul Kim, Yun Ha Lee, Young Jae Lee, Young Ho Byun, Kwang-Hee Lee, Kyusik Kim & Baik Lin Seong. (2016) Enhancement of the safety of live influenza vaccine by attenuating mutations from cold-adapted hemagglutinin. Virology 491, pages 1-9.
Crossref
Crossref
Ryuta Uraki, Subash C. Das, Masato Hatta, Maki Kiso, Kiyoko Iwatsuki-Horimoto, Makoto Ozawa, Cevayir Coban, Ken J. Ishii & Yoshihiro Kawaoka. (2014) Hemozoin as a novel adjuvant for inactivated whole virion influenza vaccine. Vaccine 32:41, pages 5295-5300.
Crossref
Crossref
Yo Han Jang, Eun-Young Lee, Young Ho Byun, Eun-Ju Jung, Yoon Jae Lee, Yun Ha Lee, Kwang-Hee Lee, Jinhee Lee & Baik Lin Seong. (2014) Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strains. Vaccine 32:5, pages 535-543.
Crossref
Crossref
Nattamon Siboonnan, Wittawat Wiriyarat, Chompunuch Boonarkart, Warunya Chakritbudsabong, Anan Jongkaewwattana, Pilaipan Puthavathana, Prasert Auewarakul & Ornpreya Suptawiwat. (2013) A serine-to-asparagine mutation at position 314 of H5N1 avian influenza virus NP is a temperature-sensitive mutation that interferes with nuclear localization of NP. Archives of Virology 158:6, pages 1151-1157.
Crossref
Crossref
Subash C. Das, Masato Hatta, Peter R. Wilker, Andrzej Myc, Tarek Hamouda, Gabrielle Neumann, James R. BakerJr.Jr. & Yoshihiro Kawaoka. (2012) Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccine. Vaccine 30:48, pages 6871-6877.
Crossref
Crossref
Koert J. Stittelaar, Edwin J.B. Veldhuis Kroeze, Larisa Rudenko, Rajeev Dhere, Sit Thirapakpoomanunt, Marie Paule Kieny & Albert D.M.E. Osterhaus. (2011) Efficacy of live attenuated vaccines against 2009 pandemic H1N1 influenza in ferrets. Vaccine 29:49, pages 9265-9270.
Crossref
Crossref
Shu Meng, Zhonghua Liu, Lili Xu, Li Li, Shan Mei, Linlin Bao, Wei Deng, Lina Li, Rongyue Lei, Liangzhi Xie, Chuan Qin & Linqi Zhang. (2011) Intranasal Immunization with Recombinant HA and Mast Cell Activator C48/80 Elicits Protective Immunity against 2009 Pandemic H1N1 Influenza in Mice. PLoS ONE 6:5, pages e19863.
Crossref
Crossref
Irina Isakova-Sivak, Li-Mei Chen, Yumiko Matsuoka, J. Theo M. Voeten, Irina Kiseleva, Jacco G.M. Heldens, Han van den Bosch, Alexander Klimov, Larisa Rudenko, Nancy J. Cox & Ruben O. Donis. (2011) Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2). Virology 412:2, pages 297-305.
Crossref
Crossref
Brian R Sloat & Zhengrong Cui. (2006) Evaluation of the immune response induced by a nasal anthrax vaccine based on the protective antigen protein in anaesthetized and non-anaesthetized mice. Journal of Pharmacy and Pharmacology 58:4, pages 439-447.
Crossref
Crossref
Robert B. Belshe, Kathryn M. Edwards, Timo Vesikari, Steven V. Black, Robert E. Walker, Micki Hultquist, George Kemble & Edward M. Connor. (2007) Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children. New England Journal of Medicine 356:7, pages 685-696.
Crossref
Crossref
Timothy J. Powell, Tara Strutt, Joyce Reome, Joseph A. Hollenbaugh, Alan D. Roberts, David L. Woodland, Susan L. Swain & Richard W. Dutton. (2007) Priming with Cold-Adapted Influenza A Does Not Prevent Infection but Elicits Long-Lived Protection against Supralethal Challenge with Heterosubtypic Virus. The Journal of Immunology 178:2, pages 1030-1038.
Crossref
Crossref
Rex Biedenbender, Stefan Gravenstein & Arvydas Ambrozaitis. 2006. Infection Management for Geriatrics in Long-Term Care Facilities. Infection Management for Geriatrics in Long-Term Care Facilities
369
390
.
D. Kumar & A. Humar. (2006) Pandemic Influenza and Its Implications for Transplantation. American Journal of Transplantation 6:7, pages 1512-1517.
Crossref
Crossref
Joseph A. Bellanti, Aderbal Sabra & Barbara J. Zeligs. (2004) Gastrointestinal immunopathology and food allergy. Annals of Allergy, Asthma & Immunology 93:5, pages S26-S32.
Crossref
Crossref